Summary : Pfizer Inc. (NYSE: PFE) announced that the Committee for Medicinal Products for Human…
PF-07321332 & Ritonavir (Paxlovid): Pfizer Gets CDSCO Panel Nod To Study For COVID Treatment. The Central…
Pfizer prepares to Launch COVID-19 Oral Antiviral Pill Reduced Risk of Hospitalization or Death by 89% in Interim Analysis.
KEYPOINTS: Pfizer announced that its oral antiviral cut the risk of hospitalization or death by…